NASDAQ:LDRH - LDR Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$36.98
+0.30 (1.20%)
Get New LDR Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LDRH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LDRH

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for LDR in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $36.98.
N/A
The current consensus among 0 investment analysts is to n/a stock in LDR. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/22/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/20/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/18/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/19/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/22/2016UBS GroupDowngradeBuy ➝ Neutral$33.00 ➝ $37.00N/A
i
6/15/2016StephensDowngradeOverweight ➝ Equal WeightN/A
i
6/14/2016CowenDowngradeOutperform ➝ Market Perform$33.00 ➝ $37.00N/A
i
6/10/2016BarclaysDowngradeOverweight ➝ Equal Weight$27.00 ➝ $37.00N/A
i
Rating by Matthew Taylor at Barclays PLC
6/9/2016Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$33.00 ➝ $37.00N/A
i
6/8/2016GabelliDowngradeBuy ➝ HoldN/A
i
Rating by J. Tsai at Gabelli
6/7/2016William BlairDowngradeOutperform ➝ Market PerformN/A
i
Rating by K. Krum at William Blair
6/7/2016Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$37.00N/A
i
Rating by Matthew O'Brien at Piper Jaffray Companies
5/27/2016BarclaysInitiated CoverageOverweight$27.00N/A
i
(Data available from 4/18/2016 forward)
LDR logo
LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company's primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company's VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company's Mobi non-fusion platform is underlined by Mobi-C, a cervical disc replacement device with a mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc. The Company's traditional fusion products include Easyspine, MC+, ROI, ROI-T, SpineTune and C-Plate.
Read More

Today's Range

Now: $36.98
$36.98
$36.98

50 Day Range

MA: N/A

52 Week Range

Now: $36.98
$16.33
$47.12

Volume

N/A

Average Volume

773,189 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of LDR?

The following sell-side analysts have issued stock ratings on LDR in the last year:
View the latest analyst ratings for LDRH.

What is the current price target for LDR?

0 Wall Street analysts have set twelve-month price targets for LDR in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for LDR in the next year.
View the latest price targets for LDRH.

What is the current consensus analyst rating for LDR?

LDR currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for LDRH.

How do I contact LDR's investor relations team?

LDR's physical mailing address is 13785 N Highway 183 Ste 200, AUSTIN, TX 78750-1895, United States. The medical device company's listed phone number is +1-512-3443333. The official website for LDR is www.ldr.com.